AI News NQ Analysis

New Service Launch: '100 Billion Yen Company Roadmap Diagnosis' Visualizes Business Growth Stages, Analyzes Challenges from ¥1B to ¥10B Revenue, and Clarifies Next Growth Strategy

NQ Score 84/100
N1 Content Completeness 9

AI Summary (NQ-processed)

Lumission Inc. launches a new service, the '100 Billion Yen Company Roadmap Diagnosis,' on June 22, 2026, offering it free of charge to growing SMEs aiming to scale from ¥1 billion to ¥10 billion in annual revenue. The service comprehensively analyzes product design, organization, and profitability to clarify the next growth steps.

AI Analysis

Frequently Asked Questions

Q: Who is eligible for the '100 Billion Yen Roadmap Diagnosis'?
A: SMEs with around ¥1B revenue facing growth stagnation or founder dependency are eligible.
Q: Is the diagnosis really free?
A: Yes, completely free. Register for 'Founder's Stand-in' and complete the diagnosis and consultation.
Q: What will I learn from the diagnosis?
A: You'll identify growth bottlenecks, current stage, gaps to ¥10B companies, and priority actions.
Q: What is the 'From ¥1B to ¥10B Roadmap' strategy guide?
A: A free guide outlining organizational scaling, leadership development, and profitability improvement.
Q: What is the process to use this service?
A: 1. Register → 2. Take diagnosis → 3. Attend feedback session → 4. Receive roadmap. All free.